Androgens and erythropoiesis: Past and present

被引:150
作者
Shahani, S. [2 ]
Braga-Basaria, M.
Maggio, M. [3 ]
Basaria, S. [1 ]
机构
[1] Boston Univ, Sch Med, Div Endocrinol & Metab, Boston, MA 02118 USA
[2] Baylor Coll Med, Div Endocrinol & Metab, Houston, TX 77030 USA
[3] Univ Parma, Div Endocrinol & Metab, I-43100 Parma, Italy
关键词
Androgens; anemia; erythropoiesis; polycythemia; GROWTH-FACTOR-I; CORONARY HEART-DISEASE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; CHRONIC-RENAL-FAILURE; BLOOD-VOLUME CHANGES; APLASTIC-ANEMIA; TESTOSTERONE ENANTHATE; BONE-MARROW; OLDER MEN; REFRACTORY-ANEMIA;
D O I
10.1007/BF03345745
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Association between androgens and erythropoiesis has been known for more than seven decades. Androgens stimulate hematopoietic system by various mechanisms. These include stimulation of erythropoietin release, increasing bone marrow activity and iron incorporation into the red cells. Before the discovery of recombinant erythropoietin (rhEpo), androgens were used in the treatment of anemia associated with renal disease, bone marrow suppression, and hypopituitarism. Anabolism is an additional advantage of androgen therapy. Furthermore, in light of recent reports regarding adverse effects of rhEpo, the role of androgen therapy in various types of anemias should be readdressed. Polycythemia remains a known side effect of androgen therapy. In this review, we will briefly discuss the initial animal and human studies which demonstrated the role of androgens in the treatment of anemia, their mechanism of action, a detailed account of the efficacy of androgens in the treatment of various anemias, the erythropoietic side effects of androgens and finally, the relationship between hematocrit levels and cardiovascular disease. (J. Endocrinol. Invest. 32: 704-716, 2009) (C) 2009, Editrice Kurtis
引用
收藏
页码:704 / 716
页数:13
相关论文
共 175 条
[1]   ERYTHROPOIETIN AND ERYTHROPOIESIS IN ANEMIC MAN FOLLOWING ANDROGENS [J].
ALEXANIAN, R .
BLOOD-THE JOURNAL OF HEMATOLOGY, 1969, 33 (04) :564-+
[2]   ATTAINMENT AND MAINTENANCE OF AZOOSPERMIA WITH COMBINED MONTHLY INJECTIONS OF DEPOT MEDROXYPROGESTERONE ACETATE AND TESTOSTERONE ENANTHATE [J].
ALVAREZSANCHEZ, F ;
FAUNDES, A ;
BRACHE, V ;
LEON, P .
CONTRACEPTION, 1977, 15 (06) :635-648
[3]   Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone [J].
Amory, JK ;
Watts, NB ;
Easley, KA ;
Sutton, PR ;
Anawalt, BD ;
Matsumoto, AM ;
Bremner, WJ ;
Tenover, JL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :503-510
[4]  
[Anonymous], INTERMEDIARY METABOL
[5]   Prevalence of anemia in skilled-nursing home residents [J].
Artz, AS ;
Fergusson, D ;
Drinka, PJ ;
Gerald, M ;
Gravenstein, S ;
Lechich, A ;
Silverstone, F ;
Finnigan, S ;
Janowski, MC ;
McCamish, MA ;
Ershler, WB .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2004, 39 (03) :201-206
[6]   TREATMENT OF APLASTIC-ANEMIA (AA) WITH ANTILYMPHOCYTE GLOBULIN (ALG) AND METHYLPREDNISOLONE (MPRED) WITH OR WITHOUT ANDROGENS - A RANDOMIZED TRIAL FROM THE EBMT-SAA WORKING PARTY [J].
BACIGALUPO, A ;
CHAPLE, M ;
HOWS, J ;
VANLINT, MT ;
MCCANN, S ;
MILLIGAN, D ;
CHESSELLS, J ;
GOLDSTONE, AH ;
OTTOLANDER, J ;
VANTVEER, ET ;
COMOTTI, B ;
COSER, P ;
BROCCIA, G ;
BOSI, A ;
LOCASCIULLI, A ;
CATALANO, L ;
BATTISTA, R ;
ARCESE, W ;
CAROTENUTO, M ;
MARMONT, AM ;
SMITH, ECG .
BRITISH JOURNAL OF HAEMATOLOGY, 1993, 83 (01) :145-151
[7]   ANDROGENS POTENTIATE THE EFFECTS OF ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA OF END-STAGE RENAL-DISEASE [J].
BALLAL, SH ;
DOMOTO, DT ;
POLACK, DC ;
MARCIULONIS, P ;
MARTIN, KJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (01) :29-33
[8]   Risks versus benefits of testosterone therapy in elderly men [J].
Basaria, S ;
Dobs, AS .
DRUGS & AGING, 1999, 15 (02) :131-142
[9]  
BEGHE C, 2004, AM J MED, V5, pS3
[10]  
BERNS JS, 1992, CLIN NEPHROL, V37, P264